<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<oembed>
  <author_name>okumi</author_name>
  <author_url>https://blog.hatena.ne.jp/okumi/</author_url>
  <blog_title>リプロな日記</blog_title>
  <blog_url>https://okumi.hatenablog.com/</blog_url>
  <categories>
  </categories>
  <description>中絶薬の価格（原価）への言及も The Selection and Use of Essential Medicines: Report of the WHO Expert Committee on Selection and Use of Essential Medicines, 2019 (including the 21st WHO Model List of Essential Medicines and the 7th WHO Model List of Essential Medicines for Children) The selection and use of essent…</description>
  <height>190</height>
  <html>&lt;iframe src=&quot;https://hatenablog-parts.com/embed?url=https%3A%2F%2Fokumi.hatenablog.com%2Fentry%2F2023%2F05%2F20%2F190718&quot; title=&quot;ミフェ-ミソがWHOの必須医薬品コアリストに入った時の条件 - リプロな日記&quot; class=&quot;embed-card embed-blogcard&quot; scrolling=&quot;no&quot; frameborder=&quot;0&quot; style=&quot;display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;&quot;&gt;&lt;/iframe&gt;</html>
  <image_url></image_url>
  <provider_name>Hatena Blog</provider_name>
  <provider_url>https://hatena.blog</provider_url>
  <published>2023-05-20 19:07:18</published>
  <title>ミフェ-ミソがWHOの必須医薬品コアリストに入った時の条件</title>
  <type>rich</type>
  <url>https://okumi.hatenablog.com/entry/2023/05/20/190718</url>
  <version>1.0</version>
  <width>100%</width>
</oembed>
